Ptc Therapeutics, Inc. · NASDAQ:PTCT
Sollie-Zetlmayer Hege Elisabeth received 6,000 Ptc Therapeutics, Inc. shares as an award (Form 4)
Traded Jul 28, 2026 · Filed Jul 30, 2026
On Jul 28, 2026, Sollie-Zetlmayer Hege Elisabeth (Director) received 6,000 Ptc Therapeutics, Inc. shares as an award, leaving 52,526 shares. Filed Jul 30, 2026 (Form 4).
- Awarded
- 6,000 shares
- Holding after
- 52,526 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Common Stock | Award | 4,000 | 50,526 | Direct | |
| Jul 28, 2026 | Common Stock | Award | 2,000 | 52,526 | Direct |
Source
Related
- Ptc Therapeutics, Inc.
- Sollie-Zetlmayer Hege Elisabeth
- Ptc Therapeutics, Inc. shareholders
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026